share_log
Moomoo 24/7 ·  Apr 23 09:57
Cartesian Therapeutics Shares Are Trading Higher After Leerink Partners Initiated Coverage on the Stock With an Outperform Rating and Announced a $39 Price Target
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment